Placental Vasculature for Prediction of Recurrent Fetal Growth Restriction
Launched by BENHA UNIVERSITY · May 21, 2020
Trial Information
Current as of August 02, 2025
Completed
Keywords
ClinConnect Summary
This Prospective longitudinal observational study was conducted at Benha University hospital starting from December 2016 to May 2019 after approval of faculty Research Ethics Board. Two hundred pregnant women with history of IUGR in previous pregnancy were recruited for the study after full explanation of the method, aim of work and obtaining consent. Inclusion criteria: singleton pregnancy from 11 up to 13 weeks. History of intrauterine growth restriction in previous pregnancy Exclusion criteria: Multiple pregnancies, Smoking women, and pre-existing medical disorders which may affect fetal...
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • singleton pregnancy from 11 up to 13 weeks.
- • History of intrauterine growth restriction in previous pregnancy
- • Exclusion Criteria: • Multiple pregnancies,
- • Smoking women, and
- • pre-existing medical disorders which may affect fetal growth e.g. hypertension, diabetes mellitus, thyroid dysfunction or renal impairment.
- • Ultrasound evidence of congenital anomalies.
About Benha University
Benha University, a leading institution in Egypt, is dedicated to advancing medical research and innovation through rigorous clinical trials. With a strong emphasis on multidisciplinary collaboration, the university aims to enhance healthcare outcomes by exploring novel therapeutic approaches and interventions. Its state-of-the-art facilities and commitment to ethical research practices ensure that all trials are conducted with the highest standards of integrity and scientific rigor. Benha University actively contributes to the global medical community by fostering partnerships and disseminating findings that can improve patient care and inform public health policies.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Trial Officials
khalid salama
Principal Investigator
Benha University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials